vs

Side-by-side financial comparison of Borealis Foods Inc. (BRLS) and VSEE HEALTH, INC. (VSEE). Click either name above to swap in a different company.

Borealis Foods Inc. is the larger business by last-quarter revenue ($7.1M vs $3.9M, roughly 1.8× VSEE HEALTH, INC.). Borealis Foods Inc. runs the higher net margin — -53.2% vs -200.0%, a 146.7% gap on every dollar of revenue. On growth, VSEE HEALTH, INC. posted the faster year-over-year revenue change (5.1% vs -12.0%). Over the past eight quarters, VSEE HEALTH, INC.'s revenue compounded faster (55.6% CAGR vs -2.4%).

Borealis Foods Inc is a food technology enterprise specializing in developing and producing high-quality plant-based protein products including plant-based meat alternatives. It mainly serves retail and food service customers across North America and Europe, focusing on delivering affordable, nutritious sustainable food options matching the taste of conventional animal-derived meat.

VSEE HEALTH, INC. is a US-based telehealth technology firm offering HIPAA-compliant virtual care platforms, remote consultation tools, and chronic disease management solutions. It primarily serves healthcare providers, enterprise clients and nonprofits across North America and select global markets.

BRLS vs VSEE — Head-to-Head

Bigger by revenue
BRLS
BRLS
1.8× larger
BRLS
$7.1M
$3.9M
VSEE
Growing faster (revenue YoY)
VSEE
VSEE
+17.2% gap
VSEE
5.1%
-12.0%
BRLS
Higher net margin
BRLS
BRLS
146.7% more per $
BRLS
-53.2%
-200.0%
VSEE
Faster 2-yr revenue CAGR
VSEE
VSEE
Annualised
VSEE
55.6%
-2.4%
BRLS

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BRLS
BRLS
VSEE
VSEE
Revenue
$7.1M
$3.9M
Net Profit
$-3.8M
$-7.9M
Gross Margin
14.6%
46.7%
Operating Margin
-27.1%
-87.6%
Net Margin
-53.2%
-200.0%
Revenue YoY
-12.0%
5.1%
Net Profit YoY
21.8%
-144.7%
EPS (diluted)
$-0.18
$-0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BRLS
BRLS
VSEE
VSEE
Q4 25
$3.9M
Q3 25
$7.1M
$4.0M
Q2 25
$7.2M
$3.4M
Q1 25
$6.8M
$3.3M
Q4 24
$6.8M
$3.7M
Q3 24
$8.1M
$3.4M
Q2 24
$5.5M
$1.7M
Q1 24
$7.9M
$1.6M
Net Profit
BRLS
BRLS
VSEE
VSEE
Q4 25
$-7.9M
Q3 25
$-3.8M
$-289.7K
Q2 25
$-4.6M
$-2.6M
Q1 25
$-4.2M
$-4.0M
Q4 24
$-5.8M
$-3.2M
Q3 24
$-4.8M
$-53.9M
Q2 24
$-6.3M
$-634.1K
Q1 24
$-8.4M
$62.8K
Gross Margin
BRLS
BRLS
VSEE
VSEE
Q4 25
46.7%
Q3 25
14.6%
52.1%
Q2 25
7.2%
46.9%
Q1 25
13.1%
56.0%
Q4 24
3.7%
63.8%
Q3 24
15.8%
83.0%
Q2 24
7.7%
45.4%
Q1 24
3.1%
76.2%
Operating Margin
BRLS
BRLS
VSEE
VSEE
Q4 25
-87.6%
Q3 25
-27.1%
-51.7%
Q2 25
-46.7%
-66.5%
Q1 25
-42.6%
-55.1%
Q4 24
-68.4%
-81.1%
Q3 24
-44.8%
-1737.8%
Q2 24
-94.8%
-54.5%
Q1 24
-88.3%
6.4%
Net Margin
BRLS
BRLS
VSEE
VSEE
Q4 25
-200.0%
Q3 25
-53.2%
-7.3%
Q2 25
-64.0%
-77.1%
Q1 25
-61.2%
-119.2%
Q4 24
-85.3%
-85.9%
Q3 24
-59.8%
-1607.5%
Q2 24
-115.0%
-37.0%
Q1 24
-106.8%
3.9%
EPS (diluted)
BRLS
BRLS
VSEE
VSEE
Q4 25
$-0.31
Q3 25
$-0.18
$-0.02
Q2 25
$0.21
$-0.16
Q1 25
$-0.20
$-0.24
Q4 24
$-0.82
$-1.96
Q3 24
$-0.23
$-3.58
Q2 24
$0.29
$-0.12
Q1 24
$-0.49
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BRLS
BRLS
VSEE
VSEE
Cash + ST InvestmentsLiquidity on hand
$5.3M
Total DebtLower is stronger
$2.7M
Stockholders' EquityBook value
$-12.9M
$5.5M
Total Assets
$56.3M
$22.4M
Debt / EquityLower = less leverage
0.50×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BRLS
BRLS
VSEE
VSEE
Q4 25
$5.3M
Q3 25
$472.8K
Q2 25
$291.6K
Q1 25
$410.1K
Q4 24
$326.1K
Q3 24
$2.3M
Q2 24
$1.1M
Q1 24
$724
Total Debt
BRLS
BRLS
VSEE
VSEE
Q4 25
$2.7M
Q3 25
$3.4M
Q2 25
$3.0M
Q1 25
$2.6M
Q4 24
$1.9M
Q3 24
$1.9M
Q2 24
$2.4M
Q1 24
Stockholders' Equity
BRLS
BRLS
VSEE
VSEE
Q4 25
$5.5M
Q3 25
$-12.9M
$-5.6M
Q2 25
$-9.2M
$-5.7M
Q1 25
$-4.8M
$-3.5M
Q4 24
$-695.9K
$-18.5K
Q3 24
$5.1M
$933.1K
Q2 24
$9.9M
$53.1M
Q1 24
$16.2M
$-13.2M
Total Assets
BRLS
BRLS
VSEE
VSEE
Q4 25
$22.4M
Q3 25
$56.3M
$18.7M
Q2 25
$57.3M
$18.2M
Q1 25
$58.4M
$19.4M
Q4 24
$60.0M
$20.0M
Q3 24
$61.9M
$22.3M
Q2 24
$63.6M
$78.6M
Q1 24
$70.3M
$1.4M
Debt / Equity
BRLS
BRLS
VSEE
VSEE
Q4 25
0.50×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
2.08×
Q2 24
0.05×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BRLS
BRLS
VSEE
VSEE
Operating Cash FlowLast quarter
$-190.6K
$-1.9M
Free Cash FlowOCF − Capex
$-1.9M
FCF MarginFCF / Revenue
-49.2%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-3.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BRLS
BRLS
VSEE
VSEE
Q4 25
$-1.9M
Q3 25
$-190.6K
$-754.5K
Q2 25
$-2.2M
$-324.6K
Q1 25
$-1.4M
$-440.5K
Q4 24
$-819.4K
$-3.0M
Q3 24
$-3.3M
$-221.0K
Q2 24
$-4.2M
$-3.2M
Q1 24
$-6.8M
$579.3K
Free Cash Flow
BRLS
BRLS
VSEE
VSEE
Q4 25
$-1.9M
Q3 25
$-761.8K
Q2 25
$-328.2K
Q1 25
$-1.4M
$-452.4K
Q4 24
$-951.6K
$-3.0M
Q3 24
$-3.7M
$-226.0K
Q2 24
$-4.7M
$-3.2M
Q1 24
$-7.3M
$570.5K
FCF Margin
BRLS
BRLS
VSEE
VSEE
Q4 25
-49.2%
Q3 25
-19.1%
Q2 25
-9.7%
Q1 25
-20.3%
-13.6%
Q4 24
-14.1%
-79.8%
Q3 24
-46.1%
-6.7%
Q2 24
-86.7%
-187.6%
Q1 24
-92.7%
35.2%
Capex Intensity
BRLS
BRLS
VSEE
VSEE
Q4 25
0.2%
Q3 25
0.2%
Q2 25
0.1%
Q1 25
0.2%
0.4%
Q4 24
2.0%
0.1%
Q3 24
5.6%
0.1%
Q2 24
9.4%
2.1%
Q1 24
7.0%
0.5%
Cash Conversion
BRLS
BRLS
VSEE
VSEE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
9.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BRLS
BRLS

Segment breakdown not available.

VSEE
VSEE

Professional Services And Other Fees$3.1M79%
Other$823.2K21%

Related Comparisons